Carregant...
Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas
Current interest in proteasome inhibitors for cancer therapy has stimulated considerable research efforts to identify the molecular pathway to their cytotoxicity with a view to identifying the mechanisms of sensitivity and resistance as well as informing the development of new drugs. Zhao and Vuori...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3203852/ https://ncbi.nlm.nih.gov/pubmed/22034840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7007-9-72 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|